C12N 2770/32663
By chemical treatment
Official title: by chemical treatment
C12N2770/32663 (By chemical treatment) appears on 7 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 7
- Assignees
- 11
- Inventors
- 29
- Latest grant
- 27 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Process for enterovirus purification and inactivation and vaccine compositions obtained thereof27 Feb 2024US 11,911,457 B2Bharat Biotech International Limited
- Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof24 Oct 2023US 11,793,869 B2Serum Institute of India Pvt Ltd
- Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof26 Nov 2019US 10,485,862 B2Serum Institute of India Pvt Ltd
- Methods for the prevention of aggregation of viral components25 Sep 2018US 10,080,793 B2De Staat Der Nederlanden, Vert.Door De Minister Van Vws, Ministerie Van Volksgezonheid, Welzijn En Sport
- Method for inactivating a virus6 Apr 1999US 5,891,705 APentose Pharmaceuticals, Inc.
- Viral inactivation method, method for producing dried amnion, and dried amnion15 Dec 2022US 2022/0396779 A1Sakura Seiki Co., Ltd.
- A process for enterovirus purification and inactivation and vaccine compositions obtained thereof3 Dec 2020US 2020/0376110 A1Bharat Biotech International Limited
- Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof19 Mar 2020US 2020/0085940 A1Serum Institute of India Pvt Ltd
- Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof7 Dec 2017US 2017/0348411 A1Serum Institute of India Private Limited
- Methods for the prevention of aggregation of viral components30 Jun 2016US 2016/0184423 A1De Staat der Nederlanden, Vert_door de minister van VWS, Ministerie van Volksgezonheid, Welzijn en
Most cited
By later US patents
- Method for inactivating a virus36US 5,891,705 APentose Pharmaceuticals, Inc. · 1999
- Use of azoles as virucidal agents in solutions of biologically active proteins10US 5,514,781 ABayer Aktiengesellschaft · 1996
- Methods for the prevention of aggregation of viral components6US 10,080,793 B2De Staat Der Nederlanden, Vert.Door De Minister Van Vws, Ministerie Van Volksgezonheid, Welzijn En Sport · 2018
- Method for inactivating non-enveloped viruses using a viricide-potentiating agent with a photoactivatible virucide1US 5,663,043 AHemasure, Inc. · 1997